June 2025 FDA Recall Sulfamethoxazole And Trimethoprim by Amneal Pharmaceuticals, Llc
D-0488-2025 - Microbial contamination of non-sterile products

This Class I drug recall was voluntarily initiated by Amneal Pharmaceuticals, Llc on June 2, 2025 for the product Sulfamethoxazole And Trimethoprim. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0488-2025

Reason for Recall
Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
Initiated
06-02-2025
Reported
06-18-2025
Quantity
6396 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Amneal Pharmaceuticals, LLC
Nationwide in the USA
Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets per Bottle, NDC: 65162-271-10, b) 500 Tablets per Bottle, NDC: 65162-271-50, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.

Batch or Lot Expiration Information

Lot# s: a) AM241019, AM241020, Exp. 06/30/2027 b) AM241019A, Exp 06/30/2027